BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19491171)

  • 1. For the dental patient. Osteoporosis medications and oral health.
    American Dental Association Division of Science
    J Am Dent Assoc; 2009 Jun; 140(6):812. PubMed ID: 19491171
    [No Abstract]   [Full Text] [Related]  

  • 2. Osteonecrosis in the jaws of patients who are using oral biphosphonates to treat osteoporosis.
    Dello Russo NM; Jeffcoat MK; Marx RE; Fugazzotto P
    Int J Oral Maxillofac Implants; 2007; 22(1):146-53. PubMed ID: 17340909
    [No Abstract]   [Full Text] [Related]  

  • 3. Bisphosphonates: a potential threat to your patients.
    Dreiman BB
    J Indiana Dent Assoc; 2005-2006 Winter; 84(4):4-9. PubMed ID: 16605211
    [No Abstract]   [Full Text] [Related]  

  • 4. Biphosphonates and osteonecrosis of the jaws: we need to assess for more than just heartburn.
    O'Malley P
    Clin Nurse Spec; 2006; 20(4):177-8. PubMed ID: 16849928
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral bisphosphonates and osteonecrosis of the jaw: are the MHRA recommendations appropriate?
    Compston J
    Menopause Int; 2007 Jun; 13(2):54-5. PubMed ID: 17540133
    [No Abstract]   [Full Text] [Related]  

  • 6. [Bisphosphonates (BP) and osteonecrosis of the jaws; continuous treatment with Bisphosphonates should be considered].
    Mawatari T
    Clin Calcium; 2010 Nov; 20(11):1743-7. PubMed ID: 21066910
    [No Abstract]   [Full Text] [Related]  

  • 7. Osteonecrosis of the jaws: maxillofacial recommendations for bisphosphonate prescribers.
    Landis BN; Dojcinovic I; Richter M; Hugentobler M
    J Intern Med; 2007 Jan; 261(1):101-2. PubMed ID: 17222173
    [No Abstract]   [Full Text] [Related]  

  • 8. Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw.
    Campisi G; Fedele S; Colella G; Lo Casto A; Fusco V
    J Rheumatol; 2009 Feb; 36(2):451-3; author reply 453. PubMed ID: 19208579
    [No Abstract]   [Full Text] [Related]  

  • 9. Update on oral bisphosphonates.
    Yeager AL
    J Am Dent Assoc; 2009 Jul; 140(7):828; discussion 828-9. PubMed ID: 19571041
    [No Abstract]   [Full Text] [Related]  

  • 10. Bisphosphonates.
    Blank RD
    J Am Dent Assoc; 2006 May; 137(5):584; discussion 584. PubMed ID: 16739534
    [No Abstract]   [Full Text] [Related]  

  • 11. Bisphosphonate medications and your oral health.
    J Am Dent Assoc; 2006 Jul; 137(7):1048. PubMed ID: 16803833
    [No Abstract]   [Full Text] [Related]  

  • 12. Medication-related osteonecrosis of the jaw in osteoporotic patients: prevention and management.
    Chan BH; Yee R; Puvanendran R; Ang SB
    Singapore Med J; 2018 Feb; 59(2):70-75. PubMed ID: 29568850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diphosphonate therapy and osteonecrosis of the jaw].
    Løkken P; Skoglund LA; Skjelbred P
    Tidsskr Nor Laegeforen; 2007 Aug; 127(15):1945-7. PubMed ID: 17700737
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical characterization might help in preventing osteonecrosis of the jaw.
    Kyrgidis A; Andreadis C
    Clin Cancer Res; 2008 Dec; 14(24):8321; author reply 8321-2. PubMed ID: 19088052
    [No Abstract]   [Full Text] [Related]  

  • 15. Bisphosphonate-induced osteonecrosis of the jaws: a challenge, a responsibility, and an opportunity.
    Marx RE
    Int J Periodontics Restorative Dent; 2008 Feb; 28(1):5-6. PubMed ID: 18351197
    [No Abstract]   [Full Text] [Related]  

  • 16. Bisphosphonate medications--the good, the bad, and the ugly.
    Bourgeois SL
    Tex Dent J; 2009 Jul; 126(7):596-604. PubMed ID: 19753815
    [No Abstract]   [Full Text] [Related]  

  • 17. Multiple osteonecrosis of the jaw, oral bisphosphonate therapy and refractory rheumatoid arthritis (Pathological fracture associated with ONJ and BP use for osteoporosis).
    Grana J; Mahia IV; Meizoso MO; Vazquez T
    Clin Exp Rheumatol; 2008; 26(2):384-5. PubMed ID: 18565271
    [No Abstract]   [Full Text] [Related]  

  • 18. Treating osteonecrosis.
    Harrison Z
    Br Dent J; 2006 Mar; 200(5):242-3. PubMed ID: 16528300
    [No Abstract]   [Full Text] [Related]  

  • 19. Treating osteoporosis.
    Smith G; Stassen L; Flint S
    Ir Med J; 2009 Mar; 102(3):88; author reply 89. PubMed ID: 19489199
    [No Abstract]   [Full Text] [Related]  

  • 20. Bisphosphonates, hypercalcemia of malignancy, and osteonecrosis of the jaw.
    Wynn RL
    Gen Dent; 2005; 53(6):392-5. PubMed ID: 16366043
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.